[5] It is available in combination with clioquinol, under the brand name Locacorten-Vioform (in some countries Locorten-Vioform[6]), for the treatment of otitis externa and otomycosis.

[2] In April 2023, the US Food and Drug Administration approved the first generic version of flumethasone (Bimasone), for certain diseases that cause inflammation in horses, dogs, and cats.

[3] Flumetasone is recommended for the various rheumatic, allergic, dermatologic and other disease states that are known to be responsive to anti-inflammatory drugs (i.e., corticoids) in these species.

[3] In dogs, Bimasone is approved for use for musculoskeletal conditions due to inflammation of muscles or joints, such as arthritis, osteoarthritis, intervertebral disc disease, and myositis.

[3] The drug has proven useful in treating canine ear infections (otitis externa) when used with topical medication for similar reasons.